Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model

Author: Alt V.   Heissel A.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.22, Iss.1, 2006-07, pp. : 19-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract